J. J. Kavanagh

13-cis-Retinoic Acid Plus Interferon   -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the Cervix

S. M. Lippman, J. J. Kavanagh, M. Paredes-Espinoza et al. · JNCI Journal of the National Cancer Institute · 1992 · 323 citations

Medicine, Oncology, Pharmacology +10

Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin.

David M. Gershenson, Michael B. Morris, J. J. Kavanagh et al. · Journal of Clinical Oncology · 1990 · 267 citations

Medicine, Oncology, Surgery +17

Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma.

Andrzej P. Kudelka, Damrong Tresukosol, Creighton L. Edwards et al. · Journal of Clinical Oncology · 1996 · 254 citations

Medicine, Oncology, Pharmacology +17

Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy

Elie G. Hanania, Richard E. Giles, J. J. Kavanagh et al. · Proceedings of the National Academy of Sciences · 1996 · 152 citations · Full text

Medicine, Cell Biology, Hematology +14

Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later

Claire F. Verschraegen, Mongkol Benjapibal, W. Supakarapongkul et al. · International Journal of Gynecological Cancer · 2001 · 151 citations

Medicine, Oncology, Surgery +17